Newsletter | May 4, 2022

05.04.22 -- Accelerating Development Using Solid Form Screening And Rapid Formulation Selection

 
Meeting Demands Of Accelerated Timelines Using Solid Form Screening And Rapid Formulation Selection
 

A comprehensive approach to evaluating drug molecules for the selection of a lead solid form and formulation can significantly accelerate development timelines and limit risks in later development.

Science-Based Tech Selection For Bioavailability Enhancement
 

Explore a process based on a series of inputs including the target product profile, drug properties, extensive past project experiences, technology maps, and absorption modeling.

Solid Form Screening, Rapid Formulation To Accelerate Timelines
 

See how experience, targeted testing, and basic scientific principles can quickly lead to the selection of effective and commercially viable formulations at an early stage of the development cycle.

Efficient Development Of Drug Products: Selecting A Dissolution Media
 

With so many different media available that vary widely in properties and composition, it is important to know how to select a dissolution media that can effectively test formulation robustness.

Q&A: Accelerating The Pace Of Development Using Solid Form Screening And Rapid Formulation Selection
 

Find answers about the importance of using rapid formulation selection and a wide range of tools and capabilities to guide selection of effective and commercially viable formulations at an early stage of development.

Solutions
Solid Form Services

Solid form selection involves both the chemical makeup of the solid to be manufactured as well as its crystal structure. We have defined workflows to assess and select solid forms in a cost- and time-efficient manner that meets the needs of each individual program.

Request Information